EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback  
Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from June 15, 2026 to June 19, 2026 (each inclusive), 451,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
15 June 2026	80,000	40.5971	3,247,768.00	XETR
16 June 2026	83,000	40.7738	3,384,225.40	XETR
17 June 2026	83,000	40.9359	3,397,679.70	XETR
18 June 2026	85,000	40.9633	3,481,880.50	XETR
19 June 2026	120,000	40.7805	4,893,660.00	XETR

A total of 1,517,000 shares has been acquired within the framework of the first tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.